EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Synthetic Biology and Biomaterials Strategies to Deceive the Tumor Microenvironment in CAR‐T Immunotherapy

Grazia Marsico iD, Sudarshan Gc, Velia Siciliano iD

Small · 2025

DOI: 10.1002/smll.202506429 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Small, 2025. Verfasst von Grazia Marsico und 2 weiteren Autor:innen. Beteiligte Einrichtung: Synthetic and Systems Biology Lab for Biomedicine, Istituto Italiano di Tecnologia-IIT, Largo Barsanti e Matteucci, Naples, 80125, Italy. Hauptthemen laut MEDLINE: Tumor Microenvironment, Biocompatible Materials, Synthetic Biology, Immunotherapy. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 164 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: HORIZON EUROPE European Research Council, Fondazione AIRC per la ricerca sul cancro ETS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chimeric antigen receptor (CAR)‐T cell immunotherapy has emerged as a groundbreaking approach in cancer treatment, offering new hope across various malignancies. However, its success against solid tumors remains limited due to critical challenges, including off‐tumor, on‐target toxicity, immune resistance, poor T cell infiltration into the tumor microenvironment (TME), and T cell exhaustion. In response, interdisciplinary innovations in synthetic biology and biomaterials are redefining how can be engineer smarter, more responsive CAR‐T cells. Recent advances have introduced biomaterials not only as precision delivery vehicles but also as artificial antigen‐presenting cells (APCs), high‐throughput screening platforms, and tools to replicate the complex biomechanical landscape of the TME. This review highlights these cutting‐edge strategies, emphasizing how biomaterials and synthetic circuits can aid studies and strategies to enhance CAR‐T cell efficacy in solid tumors while minimizing adverse effects. Future directions at the intersection of tumor‐inspired biomaterials and T cell engineering, envisioning a new generation of CAR‐T therapies tailored to overcome the formidable barriers of the TME are also explored.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tumor MicroenvironmentBiocompatible MaterialsSynthetic BiologyImmunotherapyReceptors, Chimeric AntigenImmunotherapy, AdoptiveHumansNeoplasmsT-LymphocytesAnimals

Stichwörter der Autor:innen

CAR‐Tbiomaterialsdelivery systemsex vivo mechanical modelsimmunotherapysolid tumor microenvironmentsynthetic biology

Substanzen

Biocompatible MaterialsReceptors, Chimeric Antigen

Autor:innen und Institutionen

  • Synthetic and Systems Biology Lab for Biomedicine, Istituto Italiano di Tecnologia-IIT, Largo Barsanti e Matteucci, Naples, 80125, Italy.

ORCID-Profile: Grazia Marsico, Velia Siciliano

Förderung

  • HORIZON EUROPE European Research Council
  • Fondazione AIRC per la ricerca sul cancro ETS

Zitieren

APA

Marsico, G., Gc, S., & Siciliano, V. (2025). Synthetic Biology and Biomaterials Strategies to Deceive the Tumor Microenvironment in CAR‐T Immunotherapy. Small. https://doi.org/10.1002/smll.202506429

Vancouver

Marsico G, Gc S, Siciliano V. Synthetic Biology and Biomaterials Strategies to Deceive the Tumor Microenvironment in CAR‐T Immunotherapy. Small. 2025. doi:10.1002/smll.202506429

BibTeX
@article{Marsico2025,
  author = {Marsico, Grazia and Gc, Sudarshan and Siciliano, Velia},
  title = {Synthetic Biology and Biomaterials Strategies to Deceive the Tumor Microenvironment in CAR‐T Immunotherapy},
  journal = {Small},
  year = {2025},
  doi = {10.1002/smll.202506429}
}
Kostenlos starten →